Shares of biomedical products company Cerus Corporation (NASDAQ: CERS) jumped over 21% this morning, after the company released third-quarter 2017 financial results following market close yesterday. Cerus reported growing revenue and a shrinking net loss, and said it had made several inroads to expand its business in Europe.